Navigation Links
AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University
Date:2/8/2010

License will accelerate the development of prostratin—the first in a new class of drugs for the treatment of HIV/AIDS.

(PRWEB) February 8, 2010 --AIDS Research Alliance announced today the signing of a new licensing agreement with Stanford University, transferring exclusive rights of a novel technology developed by Dr. Paul Wender and colleagues of Stanford to AIDS Research Alliance. This new technology (Science, Vol 320, p 649-652, 2 May 2008) will allow AIDS researchers to synthesize the natural compound, prostratin. Early tests conducted at the National Cancer Institute (NCI) and on-going pre-clinical studies conducted by AIDS Research Alliance indicate that prostratin targets latent HIV—the virus not killed by existing anti-HIV therapies. Previously, prostatin had to be collected from natural resources—an expensive and cumbersome process.



“Dr. Wender’s genius removes a major hurdle to the therapeutic development of this promising compound,” said Carolyn H. Carlburg, President & CEO of AIDS Research Alliance. The ability to produce prostratin synthetically will significantly reduce future costs, making prostratin a more viable drug candidate, Carlburg said.

“When used in combination with existing antiretroviral drugs, prostratin may one day help treating physicians eradicate all virus from the body—a feat not yet possible using existing therapies,” stated Dr. Stephen J. Brown, Medical Director at AIDS Research Alliance.

Dr Brown explains: “Current therapies suppress the virus, but they do not completely eradicate virus from the body. Rather, some viral particles lay dormant in pockets or “reservoirs,” avoiding the reach of today’s anti-HIV drugs. When existing treatments are interrupted, the HIV reservoir floods the body with new virus, re-igniting the infection. Thus, no cure for AIDS is possible without emptying the HIV reservoir.”

“AIDS Research Alliance has the only new drug in development that targets the HIV reservoir,” states Dr. Brown. AIDS Research Alliance has been studying how to flush virus from the HIV reservoir for more than a decade, said Dr. Brown.    

If approved by the U.S. Food & Drug Administration (FDA), prostratin would be the first in a new class of drugs and unveil a novel way to treat HIV/AIDS, Carlburg says.    

AIDS Research Alliance on Wikipedia

About AIDS Research Alliance. AIDS Research Alliance is the nation’s only independent, not-for-profit research organization licensed by the National Institutes of Health to develop an anti-HIV drug. AIDS Research Alliance helped to develop about half of current anti-HIV drugs. AIDS Research Alliance conducts research seeking an HIV vaccine and a cure for AIDS. The U.S. Food & Drug Administration conducted a preliminary review of AIDS Research Alliance’s prostratin data in February 2009. Additional pre-clinical studies will continue over the next year.    

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3532854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Marijuana ineffective as an Alzheimers treatment: UBC-Vancouver Coastal Health research
2. Nuvo Research announces early redemption of 5% convertible debentures
3. Researcher to track spread of disease, malware and power outages
4. UCSF Researchers Identify Regulator of Human Sperm Cells
5. Octapharma Accepting Applications for Research Grants Through March 31
6. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
7. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
8. Developing a cyberinfrastructure for comparative effectiveness in cancer research
9. Women should be allowed to eat, drink during labor: Queens University researcher
10. Parkinsons disease research uncovers social barrier
11. Fear of Frailty: Research Shows Lack of Activity Threatens Seniors' Independence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University
(Date:6/28/2017)... ... ... with a remote control has seen the never-ending twists on the house flipping show genre. ... in no time. But what about the buyers of the flipper's flip. , ... flipped house. An email recently sent to Gary Case said, “Just closed on a ...
(Date:6/28/2017)... ... 28, 2017 , ... American Farmer proudly announces the participation of Pure Line ... series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on ... garden pea seed. As demand grew, the small company located in Moscow, Idaho extended ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... the surrounding regions access to insurance assistance and financial planning services, is announcing ... to assist families in the region facing financial crisis. , Matthew 25: Ministries ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 ... survey data released today by the American Society for Dermatologic Surgery ... the percentage of consumers considering a cosmetic medical procedure has doubled since 2013. ...
(Date:6/27/2017)... ... ... The Congressional Budget Office (CBO) projects that the Better Care Reconciliation Act ... Affordable Care Act (ACA), would result in 22 million Americans losing their health insurance ... than 20 million Americans have gained health insurance under the ACA, and from 2013 ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... BELL, Pa. , June 1, 2017 ... (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma ... investment in Nutriceutical Holdings by KD Pharma Group. KD ... Holdings with the option to acquire the entire company. ... partner in KD. They are committed to growing the ...
(Date:5/29/2017)... TEL AVIV, Israel, May 29, 2017  Cellect Biotechnology ... of innovative technology which enables the functional selection of ... financial results for the first quarter ended March 31 ... pleased with our accomplishments in the first quarter of ... the first quarter, we announced the treatment of the ...
(Date:5/23/2017)... 23, 2017  Leaf Healthcare, recognized for developing ... for pressure ulcer prevention, will unveil its comprehensive ... Critical Care Nurses, National Teaching Institute and Critical ... The Leaf Patient Monitoring System is the first ... environment.  The system seamlessly tracks patient movement throughout ...
Breaking Medicine Technology: